Sentence examples for overweight management from inspiring English sources

34– 36 The 2-year Behavioral Modification and Lorcaserin for Obesity and Overweight Management in Diabetes Mellitus 34 (BLOOM) trial evaluated 3,182 overweight or obese individuals (with ≥1 comorbidity, excluding diabetes), and demonstrated significant weight loss in the lorcaserin versus placebo group after 1 year (mean weight loss: −5.8 kg and −2.2 kg, respectively).

The effects of lorcaserin in 604 obese individuals with diabetes on therapy with variable glycemic control (hemoglobin A1c [HbA1c] 7.0%10.00%) were specifically evaluated in the Behavioral Modification and Lorcaserin for Obesity and Overweight Management in Diabetes Mellitus (BLOOM-DM) study.

For those who are overweight, weight management (i.e., weight loss and/or prevention of weight gain) is important to alleviate overweight related health problems and to reduce chances of developing cardiovascular diseases and diabetes [ 3].

Further research is recommended into parental behavioural cognitions regarding overweight prevention and management for different ethnicities.

A cross-sectional survey was conducted to collect information from parents about overweight prevention and management for their children.

Despite accumulating research into perceptions of adolescents, parents and stakeholders regarding the causes of overweight and suggested management strategies; there has been limited evidence to inform the actual implementation of a community-based healthy lifestyle program.

Only 28%% reported receiving training in the past two years on active play, and few (n = 5) had received recent training on limiting sedentary behaviour or overweight and obesity management in children.

This study is the first RCT of adolescent overweight and obesity management to use a combination of methods to provide ATC as an adjunct to a healthy lifestyle program which is potentially sustainable to run in community settings.

The low correlations indicate that the intention of the parent and the actual behaviour of the child are two distinct features in the process of overweight prevention and management in children.

In the BLOOM (Behavioral Modification and Lorcaserin for Overweight and Obesity Management) trial, mean weight loss in placebo- and lorcaserin-treated subgroups (10 mg twice daily) was -2.2 kg (-2.2%) and -5.8 kg (-5.8%), respectively, with 20.3 and 47.5% of these subjects achieving ≥ 5% weight loss [17].

The differences between the response groups of native Dutch and Turkish descent in background characteristics and in their beliefs about overweight prevention or management were explored, using Chi-square tests for categorized variables, t-tests for normally distributed variables and Mann–Whitney tests for skewed variables.